General medical with depression drugs associated
- PMID: 19724774
- PMCID: PMC2729620
General medical with depression drugs associated
Abstract
Drug-induced depression has been the focus of intense scrutiny by the US Food and Drug Administration and has serious clinical and medicolegal implications. "Gold standard" studies of drug-induced depression-involving randomized, placebo-controlled design and direct assessment of depressive symptoms-are lacking. Based on the available literature, our review suggests that only a few types of drugs are strongly linked with induction of depression. However, the potential for idiosyncratic reactions-not necessarily detected in large-scale studies-suggests that particular caution and careful monitoring are warranted with several types of drugs, including isotretinoin, rimonabant, and alpha interferons.
Keywords: depressogenic; depressogenic drugs; drug-induced depression; iatrogenic depression; secondary depression.
References
-
- US Food and Drug Administration. FDA Issues Public Health Advisory on Chantix. [November 6, 2008]. http://www.fda.gov/bbs/topics/NEWS/2008/NEW01788.html.
-
- US Food and Drug Administration. Information for Healthcare Professionals Suicidality and Antiepileptic Drugs. [November 6, 2008]. http://www.fda.gov/Cder/Drug/Info Sheets/HCP/antiepilepticsHCP.htm.
-
- Summary Minutes. FDA Advisory Committee Meeting; 13 June 2007; FDA.
-
- US Food and Drug Administration. Antidepressant Use in Children, Adolescents, and Adults. [November 6, 2008]. http://www.fda.gov/cder/drug/antid epressants/default.htm.
-
- Freis ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med. 1954;251:1006–1008. - PubMed
LinkOut - more resources
Full Text Sources